OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Alzheimers Disease is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Validation of Spatial Orientation Screening questionnaire for use in memory clinic patients	106
Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's disease	104
Amyloid-β positivity is less prevalent in cognitively unimpaired KLOTHO KL-VS heterozygotes	97
A longitudinal cohort study demonstrating the beneficial effect of moderate consumption of green tea and coffee on the prevention of dementia: The JPHC Saku Mental Health Study	91
The partner paradox: How can we better understand shared cognitive decline in couples?	90
Mediation effect of neuropsychological factors on the relationship between social networks and mild cognitive impairment in older adults	88
Remnant cholesterol and cognitive function: Evidence from the China health and retirement longitudinal study	88
Social isolation and social cognition: A cross-sectional analysis	86
Global amyloid burden enhances network efficiency of tau propagation in the brain	86
Clinical validation of artificial intelligence-based single-subject morphometry without normative reference database	75
The association between dual sensory impairment and dementia: A systematic review and meta-analysis	73
Impacts of adapted dance on mood and physical function among persons living with Alzheimer's disease	71
A multi-modal and multi-stage region of interest-based fusion network convolutional neural network model to differentiate progressive mild cognitive impairment from stable mild cognitive impairment	66
The association of high-density lipoprotein cargo proteins with brain volume in older adults in the Atherosclerosis Risk in Communities (ARIC)	60
Association of Amyotrophic Lateral Sclerosis and Alzheimer’s Disease: New Entity or Coincidence? A Case Series	59
Research Attitudes Questionnaire scores and retention in a recruitment registry	59
Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management	58
Effects of the Participation and Involvement of Medical Professionals in Dementia Cafés on the Attendance of People with Dementia Living at Home and Their Family Caregivers	57
Capgras Syndrome as the Core Manifestation of Early-Onset Alzheimer’s Disease	55
Transfer of Tumor-Bearing Mice Intestinal Flora Can Ameliorate Cognition in Alzheimer’s Disease Mice	55
Relationship of Homocysteine Plasma Levels with Mild Cognitive Impairment, Alzheimer’s Disease, Vascular Dementia, Psychobehavioral, and Functional Complications	53
Hippocampal Glutathione Depletion and pH Increment in Alzheimer’s Disease: An in vivo MRS Study	53
Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer’s Disease	52
Physical Activity in Mild Vascular Cognitive Impairment: Results of the AFIVASC Randomized Controlled Trial at 6 Months	51
Acupuncture as a Complementary Therapy for Alzheimer’s Disease	51

Non-Pharmacological Exercise Randomized Controlled Trials in Alzheimer’s Disease	50
Did Reagan Decline?	49
CMS121, a Novel Drug Candidate for the Treatment of Alzheimer’s Disease and Age-Related Dementia	49
Oxidative Stress in Alzheimer’s Disease: The Shortcomings of Antioxidant Therapies	47
Designing Newer Omega-3 Supplementation Trials for Cognitive Outcomes: A Systematic Review Guided Analysis	47
Hormone Replacement Therapy and Alzheimer’s Disease: Current State of Knowledge and Implications for Clinical Use	46
Impact of Sarcopenia on Decline in Quality of Life in Older People with Mild Cognitive Impairment	45
Learning From Mistakes: Cognitive and Metabolic Correlates of Errors on Picture Naming in the Alzheimer’s Disease Spectrum	44
A Comparison of Well-Being of Carers of People with Dementia and Their Ability to Manage Before and During the COVID-19 Pandemic: Findings from the IDEAL Study	44
Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds	43
Alzheimer’s Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment	43
DAPI (4’,6-diamidino-2-phenylindole) Stains Compact Amyloid Plaques	42
Diagnostic Accuracy of the Swedish Version of the Rowland Universal Dementia Assessment Scale (RUDAS-S) for Multicultural Cognitive Screening in Swedish Memory Clinics	42
The Cognition and Flow Study (CogFlowS): A Mixed Method Evaluation of a Randomized Feasibility Trial of Cognitive Training in Dementia	42
Hyperorality in Frontotemporal Dementia: Cognitive and Psychiatric Symptom Profiles in Early-Stage Disease	41
Association Between Grip Strength and Cognitive Function in US Older Adults of NHANES 2011–2014	40
Experimental Periodontitis Deteriorates Cognitive Function and Impairs Insulin Signaling in a Streptozotocin-Induced Alzheimer’s Disease Rat Model	40
Identification of Early Onset Dementia in Population-Based Health Administrative Data: A Validation Study Using Primary Care Electronic Medical Records	40
Interactive Effects of Pulse Pressure and Tau Imaging on Longitudinal Cognition	40